{"id":745,"date":"2017-05-05T17:20:25","date_gmt":"2017-05-05T17:20:25","guid":{"rendered":"http:\/\/blog.valuengine.com\/?p=745"},"modified":"2017-05-05T17:20:25","modified_gmt":"2017-05-05T17:20:25","slug":"valuengine-weekly-health-care-stocks-ibm-valuation-watch-and-more","status":"publish","type":"post","link":"http:\/\/blog.valuengine.com\/index.php\/valuengine-weekly-health-care-stocks-ibm-valuation-watch-and-more\/","title":{"rendered":"ValuEngine Weekly: Health Care Stocks, IBM, Valuation Watch, and More"},"content":{"rendered":"

This week, we provide top-five ranked VE data for our Health Care stocks. We take a look at our latest data on IBM $IBM. We currently have an overvaluation watch underway.<\/strong><\/span><\/p>\n

VALUATION WATCH: Overvalued stocks now make up 61.45% of our stocks assigned a valuation and 25.36% of those equities are calculated to be overvalued by 20% or more. Thirteen sectors are calculated to be overvalued.<\/span>
\n<\/strong><\/p>\n


\nValuEngine Index Overview<\/span> <\/strong><\/h1>\n\n\n\n\n\n\n\n
Index<\/td>\nWeek Open<\/td>\nFriday AM<\/td>\nChange<\/td>\n% Change<\/td>\nYTD<\/td>\n<\/tr>\n
DJIA<\/strong><\/td>\n20962.73<\/td>\n20919.06<\/td>\n-43.67<\/td>\n-0.21%<\/td>\n5.85%<\/td>\n<\/tr>\n
NASDAQ<\/strong><\/td>\n6067.56<\/td>\n6071.55<\/td>\n3.99<\/td>\n0.07%<\/td>\n12.79%<\/td>\n<\/tr>\n
RUSSELL 2000<\/strong><\/td>\n1401.01<\/td>\n1387.75<\/td>\n-13.26<\/td>\n-0.95%<\/td>\n2.26%<\/td>\n<\/tr>\n
S&P 500<\/strong><\/td>\n2388.5<\/td>\n2390.89<\/td>\n2.39<\/td>\n0.10%<\/td>\n6.79%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

ValuEngine Market Overview<\/span> <\/strong><\/h1>\n\n\n\n\n\n\n\n
Summary of VE Stock Universe<\/td>\n<\/tr>\n
Stocks Undervalued <\/strong><\/td>\n38.55%<\/td>\n<\/tr>\n
Stocks Overvalued <\/strong><\/td>\n61.45%<\/td>\n<\/tr>\n
Stocks Undervalued by 20% <\/strong><\/td>\n16.81%<\/td>\n<\/tr>\n
Stocks Overvalued by 20% <\/strong><\/td>\n25.36%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

ValuEngine Sector Overview<\/strong><\/span><\/h1>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Sector<\/td>\nChange<\/td>\nMTD<\/td>\nYTD<\/td>\nValuation<\/td>\nLast 12-MReturn<\/td>\nP\/E Ratio<\/td>\n<\/tr>\n
Multi-Sector Conglomerates<\/a><\/td>\n-0.25%<\/td>\n-0.87%<\/td>\n6.69%<\/td>\n18.06% overvalued<\/td>\n13.74%<\/td>\n20.28<\/td>\n<\/tr>\n
Industrial Products<\/a><\/td>\n-0.29%<\/td>\n-0.46%<\/td>\n5.39%<\/td>\n15.45% overvalued<\/td>\n25.95%<\/td>\n24.39<\/td>\n<\/tr>\n
Computer and Technology<\/a><\/td>\n-0.47%<\/td>\n-0.68%<\/td>\n13.98%<\/td>\n15.35% overvalued<\/td>\n22.87%<\/td>\n30.53<\/td>\n<\/tr>\n
Finance<\/a><\/td>\n-0.23%<\/td>\n-0.24%<\/td>\n4.21%<\/td>\n11.11% overvalued<\/td>\n16.92%<\/td>\n17.69<\/td>\n<\/tr>\n
Aerospace<\/a><\/td>\n-0.40%<\/td>\n-0.96%<\/td>\n2.77%<\/td>\n10.56% overvalued<\/td>\n21.38%<\/td>\n22.84<\/td>\n<\/tr>\n
Utilities<\/a><\/td>\n-1.92%<\/td>\n-2.97%<\/td>\n6.21%<\/td>\n8.32% overvalued<\/td>\n15.74%<\/td>\n23.05<\/td>\n<\/tr>\n
Business Services<\/a><\/td>\n-0.09%<\/td>\n-0.30%<\/td>\n6.62%<\/td>\n7.89% overvalued<\/td>\n12.00%<\/td>\n24.52<\/td>\n<\/tr>\n
Consumer Discretionary<\/a><\/td>\n-0.45%<\/td>\n-0.89%<\/td>\n6.64%<\/td>\n6.98% overvalued<\/td>\n22.66%<\/td>\n26.23<\/td>\n<\/tr>\n
Consumer Staples<\/a><\/td>\n-0.32%<\/td>\n-0.78%<\/td>\n4.90%<\/td>\n5.72% overvalued<\/td>\n13.41%<\/td>\n24.80<\/td>\n<\/tr>\n
Auto-Tires-Trucks<\/a><\/td>\n-0.23%<\/td>\n-1.00%<\/td>\n6.67%<\/td>\n5.65% overvalued<\/td>\n25.31%<\/td>\n14.62<\/td>\n<\/tr>\n
Transportation<\/a><\/td>\n-0.41%<\/td>\n-0.82%<\/td>\n5.21%<\/td>\n5.52% overvalued<\/td>\n9.65%<\/td>\n20.50<\/td>\n<\/tr>\n
Construction<\/a><\/td>\n0.06%<\/td>\n-1.07%<\/td>\n11.47%<\/td>\n4.54% overvalued<\/td>\n19.51%<\/td>\n21.86<\/td>\n<\/tr>\n
Medical<\/a><\/td>\n-0.24%<\/td>\n0.17%<\/td>\n10.93%<\/td>\n0.75% overvalued<\/td>\n6.67%<\/td>\n28.03<\/td>\n<\/tr>\n
Retail-Wholesale<\/a><\/td>\n-0.76%<\/td>\n-1.03%<\/td>\n3.97%<\/td>\n0.71% overvalued<\/td>\n8.38%<\/td>\n24.16<\/td>\n<\/tr>\n
Basic Materials<\/a><\/td>\n-1.91%<\/td>\n-3.25%<\/td>\n1.95%<\/td>\n3.04% undervalued<\/td>\n19.65%<\/td>\n24.30<\/td>\n<\/tr>\n
Oils-Energy<\/a><\/td>\n-2.48%<\/td>\n-3.20%<\/td>\n-6.08%<\/td>\n8.45% undervalued<\/td>\n3.91%<\/td>\n30.06<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

\nSector Talk–Health Care<\/strong><\/span><\/h1>\n

Below, we present the latest data on Health Care stocks from our Professional Stock Analysis Service<\/a>. <\/strong>Top- five lists are provided for each category.\u00a0 We applied some basic liquidity criteria–share price greater than $3 and average daily volume in excess of 100k shares.<\/p>\n

Top-Five Health Care Stocks–Short-Term Forecast Returns<\/strong><\/span><\/p>\n\n\n\n\n\n\n\n\n
Ticker<\/strong><\/td>\nName<\/strong><\/td>\nMkt Price<\/strong><\/td>\nValuation (%)<\/strong><\/td>\nLast 12-M Return<\/strong> (%)<\/strong><\/td>\n<\/tr>\n
LCI<\/td>\nLANNETT INC<\/td>\n21.2<\/td>\n-42.01%<\/td>\n7.23%<\/td>\n<\/tr>\n
UTHR<\/td>\nUTD THERAPEUTIC<\/td>\n122.32<\/td>\n-13.39%<\/td>\n13.05%<\/td>\n<\/tr>\n
EGRX<\/td>\nEAGLE PHARMACT<\/td>\n87.39<\/td>\n-5.67%<\/td>\n132.54%<\/td>\n<\/tr>\n
SCMP<\/td>\nSUCAMPO PHARMAC<\/td>\n10.15<\/td>\n-30.46%<\/td>\n-5.49%<\/td>\n<\/tr>\n
ENDP<\/td>\nENDO INTL PLC<\/td>\n11.17<\/td>\n-75.00%<\/td>\n-59.19%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Top-Five Health Care Stocks–Momentum<\/strong><\/span><\/p>\n\n\n\n\n\n\n\n\n
Ticker<\/strong><\/td>\nName<\/strong><\/td>\nMkt Price<\/strong><\/td>\nValuation (%)<\/strong><\/td>\nLast 12-M Return<\/strong> (%)<\/strong><\/td>\n<\/tr>\n
AKAO<\/td>\nACHOGEN INC<\/td>\n24.99<\/td>\n236.31%<\/td>\n716.67%<\/td>\n<\/tr>\n
LNTH<\/td>\nLANTHEUS HLDGS<\/td>\n13.75<\/td>\nN\/A<\/td>\n597.97%<\/td>\n<\/tr>\n
EXAS<\/td>\nEXACT SCIENCES<\/td>\n31.96<\/td>\n114.71%<\/td>\n450.09%<\/td>\n<\/tr>\n
EXEL<\/td>\nEXELIXIS INC<\/td>\n22.04<\/td>\n60.06%<\/td>\n409.01%<\/td>\n<\/tr>\n
CLVS<\/td>\nCLOVIS ONCOLOGY<\/td>\n51.36<\/td>\n18.71%<\/td>\n289.39%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Top-Five Health Care Stocks–Composite Score<\/strong><\/span><\/p>\n\n\n\n\n\n\n\n\n
Ticker<\/strong><\/td>\nName<\/strong><\/td>\nMkt Price<\/strong><\/td>\nValuation (%)<\/strong><\/td>\nLast 12-M Return<\/strong> (%)<\/strong><\/td>\n<\/tr>\n
EGRX<\/td>\nEAGLE PHARMACT<\/td>\n87.39<\/td>\n-5.67%<\/td>\n132.54%<\/td>\n<\/tr>\n
UTHR<\/td>\nUTD THERAPEUTIC<\/td>\n122.32<\/td>\n-13.39%<\/td>\n13.05%<\/td>\n<\/tr>\n
AZN<\/td>\nASTRAZENECA PLC<\/td>\n30.63<\/td>\n-1.62%<\/td>\n8.39%<\/td>\n<\/tr>\n
MYL<\/td>\nMYLAN NV<\/td>\n38.01<\/td>\n-22.64%<\/td>\n-9.37%<\/td>\n<\/tr>\n
LCI<\/td>\nLANNETT INC<\/td>\n21.2<\/td>\n-42.01%<\/td>\n7.23%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Top-Five Health Care Stocks–Most Overvalued<\/strong><\/span><\/p>\n\n\n\n\n\n\n\n\n
Ticker<\/strong><\/td>\nName<\/strong><\/td>\nMkt Price<\/strong><\/td>\nValuation (%)<\/strong><\/td>\nLast 12-M Return<\/strong> (%)<\/strong><\/td>\n<\/tr>\n
LJPC<\/td>\nLA JOLLA PHARMA<\/td>\n27.69<\/td>\n300.00%<\/td>\n61.08%<\/td>\n<\/tr>\n
CYH<\/td>\nCOMMNTY HLTH SY<\/td>\n9.61<\/td>\n300.00%<\/td>\n-36.02%<\/td>\n<\/tr>\n
VIVE<\/td>\nVIVEVE MEDICAL<\/td>\n7.7<\/td>\n300.00%<\/td>\n-9.41%<\/td>\n<\/tr>\n
AKAO<\/td>\nACHOGEN INC<\/td>\n24.99<\/td>\n236.31%<\/td>\n716.67%<\/td>\n<\/tr>\n
TSRO<\/td>\nTESARO INC<\/td>\n143.59<\/td>\n223.33%<\/td>\n258.44%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

 <\/p>\n

Free Download for Readers<\/strong><\/span><\/h1>\n

As a bonus to our Free Weekly Newsletter subscribers,
\nwe are offering a FREE DOWNLOAD of one of our Stock Reports<\/strong><\/em><\/span><\/p>\n

IBM (IBM) is an information technology (IT) company. The company operates in five segments: Global Technology Services, Global Business Services, Software, Systems and Technology, and Global Financing. The Global Technology Services segment provides IT infrastructure services and business process services. The Global Business Services segment offers professional services and application management services. The Software segment consists primarily of middleware and operating systems software. The Systems and Technology segment provides computing power and storage solutions; and semiconductor technology products and packaging solutions. The Global Financing segment invests in financing assets, leverages with debt and manages the associated risks. IBM is headquartered in Armonk, New York.<\/p>\n

VALUENGINE RECOMMENDATION: ValuEngine continues its BUY recommendation on IBM for 2017-05-04. Based on the information we have gathered and our resulting research, we feel that IBM has the probability to OUTPERFORM average market performance for the next year. The company exhibits ATTRACTIVE Company Size and P\/E Ratio.<\/p>\n

You can download a free copy of detailed report on IBM (IBM) from the link below.<\/p>\n

R<\/strong><\/em>ead our Complete Rating and Forecast Report\u00a0 <\/strong><\/em>HERE.<\/strong><\/a><\/span><\/p>\n\n\n\n\n\n\n\n\n\n\n
ValuEngine Forecast<\/strong><\/td>\n<\/tr>\n
<\/td>\nTarget
\nPrice*<\/th>\n		Expected
\nReturn<\/th>\n<\/tr>\n
1-Month<\/strong><\/td>\n160.14<\/td>\n0.68%<\/td>\n<\/tr>\n
3-Month<\/strong><\/td>\n161.39<\/td>\n1.47%<\/td>\n<\/tr>\n
6-Month<\/strong><\/td>\n161.14<\/td>\n1.31%<\/td>\n<\/tr>\n
1-Year<\/strong><\/td>\n172.12<\/td>\n8.22%<\/td>\n<\/tr>\n
2-Year<\/strong><\/td>\n171.93<\/td>\n8.10%<\/td>\n<\/tr>\n
3-Year<\/strong><\/td>\n173.77<\/td>\n9.25%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Valuation & Rankings<\/strong><\/td>\n<\/tr>\n
Valuation<\/strong><\/td>\n4.59% overvalued<\/td>\nValuation Rank<\/strong>(?<\/a>)<\/td>\n54<\/td>\n<\/tr>\n
1-M Forecast Return<\/strong><\/td>\n0.68%<\/td>\n1-M Forecast Return Rank<\/strong><\/td>\n90<\/td>\n<\/tr>\n
12-M Return<\/strong><\/td>\n10.26%<\/td>\nMomentum Rank<\/strong>(?<\/a>)<\/td>\n48<\/td>\n<\/tr>\n
Sharpe Ratio<\/strong><\/td>\n-0.29<\/td>\nSharpe Ratio Rank<\/strong>(?<\/a>)<\/td>\n27<\/td>\n<\/tr>\n
5-Y Avg Annual Return<\/strong><\/td>\n-5.12%<\/td>\n5-Y Avg Annual Rtn Rank<\/strong><\/td>\n36<\/td>\n<\/tr>\n
Volatility<\/strong><\/td>\n17.62%<\/td>\nVolatility Rank<\/strong>(?<\/a>)<\/td>\n76<\/td>\n<\/tr>\n
Expected EPS Growth<\/strong><\/td>\n1.33%<\/td>\nEPS Growth Rank<\/strong>(?<\/a>)<\/td>\n23<\/td>\n<\/tr>\n
Market Cap (billions)<\/strong><\/td>\n157.62<\/td>\nSize Rank<\/strong><\/td>\n100<\/td>\n<\/tr>\n
Trailing P\/E Ratio<\/strong><\/td>\n11.74<\/td>\nTrailing P\/E Rank<\/strong>(?<\/a>)<\/td>\n88<\/td>\n<\/tr>\n
Forward P\/E Ratio<\/strong><\/td>\n11.58<\/td>\nForward P\/E Ratio Rank<\/strong><\/td>\n77<\/td>\n<\/tr>\n
PEG Ratio<\/strong><\/td>\n8.84<\/td>\nPEG Ratio Rank<\/strong><\/td>\n4<\/td>\n<\/tr>\n
Price\/Sales<\/strong><\/td>\n1.99<\/td>\nPrice\/Sales Rank<\/strong>(?<\/a>)<\/td>\n49<\/td>\n<\/tr>\n
Market\/Book<\/strong><\/td>\n8.54<\/td>\nMarket\/Book Rank<\/strong>(?<\/a>)<\/td>\n17<\/td>\n<\/tr>\n
Beta<\/strong><\/td>\n0.97<\/td>\nBeta Rank<\/strong><\/td>\n43<\/td>\n<\/tr>\n
Alpha<\/strong><\/td>\n-0.05<\/td>\nAlpha Rank<\/strong><\/td>\n40<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

<\/p>\n

<\/strong><\/p>\n

ValuEngine.com is an Independent Research Provider (IRP), producing buy\/hold\/sell recommendations, target price, and valuations on over 5,000 US and Canadian equities every trading day.<\/span><\/strong>
\n Contact ValuEngine at (800) 381-5576 or support@valuengine.com \u00a0<\/span><\/strong>
\n Visit www.ValuEngine.com for more information<\/a><\/span><\/strong><\/p>\n

\u00a0<\/span><\/strong><\/h1>\n

ValuEngine Capital Management LLC is a Registered Investment Advisory (RIA) firm that trades client accounts using ValuEngine’s award-winning stock research. <\/span><\/strong>
\n Contact ValuEngine Capital at info@valuenginecapital.com<\/span><\/strong>
\n Visit www.ValuEngineCapital.com for more information<\/a><\/span><\/strong><\/p>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

This week, we provide top-five ranked VE data for our Health Care stocks. We take a look at our latest data on IBM $IBM. We currently have an overvaluation watch underway. VALUATION WATCH: Overvalued stocks now make up 61.45% of our stocks assigned a valuation and 25.36% of those equities are calculated to be overvalued … Read more<\/a><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[39],"tags":[343,347,436,353,65,66,338,434,435,344,11,432,58,341,438,340,62,437,342,9,7,64,351,433,68,10,63,439],"_links":{"self":[{"href":"http:\/\/blog.valuengine.com\/index.php\/wp-json\/wp\/v2\/posts\/745"}],"collection":[{"href":"http:\/\/blog.valuengine.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/blog.valuengine.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/blog.valuengine.com\/index.php\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"http:\/\/blog.valuengine.com\/index.php\/wp-json\/wp\/v2\/comments?post=745"}],"version-history":[{"count":2,"href":"http:\/\/blog.valuengine.com\/index.php\/wp-json\/wp\/v2\/posts\/745\/revisions"}],"predecessor-version":[{"id":747,"href":"http:\/\/blog.valuengine.com\/index.php\/wp-json\/wp\/v2\/posts\/745\/revisions\/747"}],"wp:attachment":[{"href":"http:\/\/blog.valuengine.com\/index.php\/wp-json\/wp\/v2\/media?parent=745"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/blog.valuengine.com\/index.php\/wp-json\/wp\/v2\/categories?post=745"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/blog.valuengine.com\/index.php\/wp-json\/wp\/v2\/tags?post=745"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}